Clinical Trial Update: UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma [Phase 3]

View source ↗

Summary

This is an update on a Phase III trial (Total Therapy 4B) for low-risk multiple myeloma (NCT00734877) led by the University of Arkansas; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING